Results 261 to 270 of about 1,994,731 (278)
Some of the next articles are maybe not open access.
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Nature Reviews Drug Discovery, 2015Madduri Srinivasarao, Philip S Low
exaly
Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG)
Annales d'Endocrinologie, 2006openaire +2 more sources
Denosumab: benefits of RANK ligand inhibition in cancer patients
Current Opinion in Supportive and Palliative Care, 2011A. Lipton, I. Jacobs
semanticscholar +1 more source
Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008
Nature Reviews Drug Discovery, 2009Mayako Michino +2 more
exaly
The mechanisms of Hedgehog signalling and its roles in development and disease
Nature Reviews Molecular Cell Biology, 2013James Briscoe
exaly
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Nature Reviews Clinical Oncology, 2019Gerasimos P Sykiotis +2 more
exaly
Environmental sensing through focal adhesions
Nature Reviews Molecular Cell Biology, 2009Benjamin Geiger, Alexander Bershadsky
exaly

